Dr. Marik talks about treating asymptomatic patients with a pharmaceutical, the role and value of testing asymptomatic people, and Dr. Kory discusses the potential risks and side effects of Paxlovid.

View the full webinar here: https://odysee.com/@FrontlineCovid19CriticalCareAlliance:c/Weekly_Webinar_3222:4

Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease.

We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.

Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.

covidhealthpaul marikpaxlovidpierre kory